comparemela.com

Latest Breaking News On - ஊர்ச் ரோஹ்னர் - Page 6 : comparemela.com

Daily Update: May 13, 2021 | S&P Global

Subscribe on LinkedIn to be notified of each new Daily Update a curated selection of essential intelligence on financial markets and the global economy from S&P Global. The fallout from the Greensill Capital and Archegos Capital Management scandals is continuing to reverberate across the financial services industry likely resulting in a stricter risk management landscape. The collapse of the London-based supply chain finance company Greensill, which filed for insolvency in early March after maintaining a valuation in the billions just a few years prior, marked one of the most shocking firm failures in more than a decade. In the same month, Archegos, the family office of investor Bill Huang, couldn’t meet multiple margin calls, prompting a widespread sell-off that closed the family office, lost Mr. Huang between $8 billion-$20 billion in less than two weeks, and cut millions from major global banks’ first-quarter earnings. Both incidents may make trade credit insurers more cauti

Euromoney Why Horta-Osório should pivot Credit Suisse to Asia

With Greensill and Archegos, António Horta-Osório has more on his plate than a medieval King. But Credit Suisse’s new chair could do something that would placate doubters and please investors: pivot firmly to Asia. António Horta-Osório has been busy since he replaced Urs Rohner as chair of Credit Suisse on April 30. He hasn’t ducked the myriad challenges his new employer faces in the wake of the Greensill fiasco and the collective calumny of Archegos Capital Management. He has committed to a hands-on role in a strategic review of the Swiss bank’s risk management, culture and future options.

Investegate |GlaxoSmithKline PLC Announcements | GlaxoSmithKline PLC: Board and Committee Changes

A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;

Investegate |GlaxoSmithKline PLC Announcements | GlaxoSmithKline PLC: Result of AGM

Credit Suisse risk committee head to depart amid board reshuffle

By Aaron Nicodemus2021-05-03T20:28:00+01:00 Credit Suisse’s board member in charge of its risk committee has stepped down as fallout from “unacceptable” losses in the wake of collapses at Archegos Capital and Greensill Capital continues to roil the Swiss-based bank. Andreas Gottschling told the bank Friday he would not stand for re-election. Proxy adviser Glass Lewis and other investors had been urging shareholders to vote against extending his term. Gottschling served on the Credit Suisse board since 2017 and on the board of Credit Suisse International since 2018, according to his LinkedIn profile. Board Member Richard Meddings, chair of Credit Suisse’s audit committee, replaces Gottschling as interim chair of risk.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.